Headlines

MOPOLI Stock 9.65% Up Today

(VIANEWS) – The Market ended the session with MOPOLI (MOP.BR) jumping 9.65% to €250.00 on Tuesday while BEL 20 dropped 0.24% to €3,663.60. MOPOLI’s last close was €240.00, 14.89% below its 52-week high of €282.00. About MOPOLI Palmboomen Cultuur Maatschappij Mopoli (Palmeraies De Mopoli) N.V. invests in tropical agro industry projects in Belgium. The company…

Read More

FINANCIERE MARJOS Stock Was Up By 22.22% Today

(VIANEWS) – The Market ended the session with FINANCIERE MARJOS (FINM.PA) jumping 22.22% to €0.11 on Tuesday while CAC 40 dropped 0.3% to €7,932.82. FINANCIERE MARJOS’s last close was €0.09, 57.14% below its 52-week high of €0.21. About FINANCIERE MARJOS Financière Marjos SA, together with its subsidiaries, engages in the creation, installation, acquisition, and operation…

Read More

BERGENBIO Stock Bullish Momentum With A 13.59% Jump Today

(VIANEWS) – The Market ended the session with BERGENBIO (BGBIO.OL) jumping 13.59% to kr0.22 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.5% to kr1,275.27. BERGENBIO’s last close was kr0.19, 98.52% below its 52-week high of kr13.03. About BERGENBIO BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug…

Read More

Financiere Marjolaine Stock Surges Over 22% In Today’s Trading Session

(VIANEWS) – Investors were pleased with FINANCIERE MARJOS (FINM.PA) impressive 22.22% surge, which broke a five-session losing streak of shares. Unfortunately, however, CAC 40 experienced a slight dip, falling by 0.15% to EUR7,944.74. This recent trend suggests decreased trading activity. FINANCIERE MARJOS recently closed at EUR0.09, marking an astounding 57.14% drop from its 52-week high…

Read More

GENSIGHT BIOLOGICS Stock Impressive Jump On Monday, Outperforms Market

(VIANEWS) – The Market ended the session with GENSIGHT BIOLOGICS (SIGHT.PA) rising 32.91% to €0.53 on Monday while CAC 40 jumped 0.28% to €7,956.41. GENSIGHT BIOLOGICS’s last close was €0.40, 89.74% under its 52-week high of €3.88. About GENSIGHT BIOLOGICS GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes therapies for mitochondrial and…

Read More